Preferred Label : Pharmacogenomic Testing;

MeSH definition : The detection of genetic variability (e.g., PHARMACOGENOMIC VARIANTS) relevant to PHARMACOGENETICS and PRECISION MEDICINE. The purpose of such genetic testing is to help determine the most effective treatment options and their optimum dosages with least potential risks for DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS.;

MeSH synonym : Pharmacogenomic Testings; Pharmacogenomic Screening; Pharmacogenomic Screenings; Pharmacogenetic Screening; Pharmacogenetic Screenings; Pharmacogenetic Testing; Pharmacogenetic Testings;

DeCS synonym : Pharmacogenomic Analysis;

Related MeSH term : Pharmacogenomic Analyses; Pharmacogenetic Study; Pharmacogenetic Studies; Studies, Pharmacogenetic; Pharmacogenetic Analysis; Pharmacogenetic Analyses; Pharmacogenomic Study; Pharmacogenomic Studies;

Details


Main resources

You can consult :

The detection of genetic variability (e.g., PHARMACOGENOMIC VARIANTS) relevant to PHARMACOGENETICS and PRECISION MEDICINE. The purpose of such genetic testing is to help determine the most effective treatment options and their optimum dosages with least potential risks for DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS.

https://kce.fgov.be/fr/publications/tous-les-rapports/recours-aux-tests-pharmacogenetiques-en-belgique
2024
Belgium
technical report
french abstract
Belgium
Pharmacogenetic Test
belgium
Pharmacogenomic Testing
pharmacogenetics

---
https://www.cfp.ca/content/66/4/247
2020
Canada
journal article
Pharmacogenomic Testing

---
https://pharmactuel.com/index.php/pharmactuel/article/view/1240
2019
false
false
false
false
France
critical appraisal or critical reading
warfarin
anticoagulants
anticoagulants
thrombosis
hemorrhage
hemorrhage
Pharmacogenomic Testing
international normalized ratio
warfarin
arthroplasty
genotype
warfarin
warfarin measurement

---
MAMMAPRINT TEST FOR PERSONALISED MANAGEMENT OF ADJUVANT CHEMOTHERAPY DECISIONS IN EARLY BREAST CANCER
https://kce.fgov.be/fr/publications/tout-les-rapports/quel-role-pour-le-test-mammaprintr-dans-les-decisions-de-chimiotherapie-adjuvante-en-cas-de-cancer
2018
false
false
false
Belgium
French
English
technical report
MammaPrint
gene expression profiling
chemotherapy, adjuvant
breast neoplasms
breast neoplasms
Pharmacogenomic Testing
Clinical Decision-Making
Early Stage Breast Carcinoma
quality of life
continuity of patient care
Evidence-Based medicine
risk assessment
Limited Stage
neoplasm metastasis
risk

---
https://dumas.ccsd.cnrs.fr/dumas-01977033/document
2018
France
dissertations, academic
pharmacogenetics
cytochrome-c oxidase
cytochrome p-450 cyp2d6
case management
Pharmacogenomic Testing
review literature as topic
Cytochrome P-450 CYP2C19
has patient
cytochromes c'
cytochromes
Literature
pharmacogenetics
cytochromes c'
cytochromes

---
https://smf.swisshealthweb.ch/fr/article/doi/fms.2012.01296/
2012
false
Switzerland
French
Pharmacogenomic Testing
pharmacogenetics
journal article

---
https://smf.swisshealthweb.ch/fr/article/doi/fms.2012.01292/
2012
false
Switzerland
French
Pharmacogenomic Testing
pharmacogenetics
journal article

---
http://www.em-consulte.com/article/pii/S0399-8320(08)00649-0
10.1016/j.gcb.2008.10.014
2009
France
teaching material
journal article
pharmacology
mercaptopurine
pharmacologist
azathioprine
pharmacogenetics
complication, nos
Intraspinal abscess
Mercaptopurine
azathioprine
Pharmacogenomic Testing
pharmacogenetics
Mercaptopurine

---
https://www.revmed.ch/RMS/2008/RMS-165/Tests-pharmacogenetiques-bientot-avant-chaque-prescription
2008
false
Switzerland
French
Pharmacogenetic Test
Pharmacogenomic Testing
genetic testing
tamoxifen
anticoagulants
administration, oral
anti-retroviral agents
pharmacogenetics
journal article

---
Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.